Related Experiment Video
Updated: Aug 12, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Perspectives in chronic lymphocytic leukemia biology and management
1Unité d'Immuno-Hématologie et d'Immunopathologie, Institut Pasteur, 28 rue du Dr Roux F-75724 Paris cedex 15, France. dighiero@pasteur.fr
Hematology/Oncology Clinics of North America
|August 25, 2004
Abstract:
Considerable progress has been achieved in the comprehension of the pathogenesis, prognosis, assessment, and treatment of chronic lymphocytic leukemia. However, this progress also has introduced new enigmas in the fields of biology, prognosis, and treatment. This article discusses some unanswered questions in these different topics.
